Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook-square
  • x
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Uncategorized

Uncategorized

Addendum: COVID-19 Vaccination Updated Sinopharm Vaccine Guidelines

Ijaz Mustafa Uncategorized March 12, 2021January 18, 2022
20210310-COVID-19-Vaccination-Updated-Sinopharm-Vaccine-Guidelines-Addendum_5901-2Download

Guidelines to establish Adult Vaccination Center(AVC) in private healthcare facilities

Ijaz Mustafa Uncategorized February 16, 2021January 18, 2022

Guidelines-for-AVC-in-Privater-Sector-15-2-2021-1-10Download

Application for No Objection Certificate Under S. R. O. 135(I)2021 Dated 2nd February, 2021.

Ijaz Mustafa Uncategorized February 11, 2021January 18, 2022
Application-for-NOCDownload

Two COVID-19 vaccines granted Emergency Use Authorization (EUA) in Pakistan

Ijaz Mustafa Uncategorized January 11, 2021January 18, 2022
Pressnote_covid_vaccine_drap-edited-tracked-1Download
  • Next →
  • DRAP at a Glance
    • What We Do?
    • Vision & Mission
    • CEO’s Message
  • Organization
    • Organizational Structure
    • Divisions
    • Policy Board
    • Members of Authority
    • Information and Transparency
    • Strategic Plan 2026-2030
  • Legislation
    • Acts
    • Rules
    • Regulations
    • SROs
    • Notifications
  • Boards and Committees
    • Central Licensing Board
    • Registration Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee
    • Committee on Advertisements
  • Quality Management System
    • Quality Policy
    • Management Reviews
  • Product Recalls
    • Recall Alerts
    • Recalls and Rapid Alerts
  • Safety Communication
    • Safety Alerts
    • Health Professional Alerts
    • Pharmacovigilance Newsletter
  • Safety Reporting
    • How DRAP Monitor Safety
    • Adverse Events Reporting
    • Pharmacovigilance System
    • Product Quality Defects
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Invitation for Comments
    • About Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee
  • Drugs
  • Medical Devices
  • Alternative Medicines
  • Controlled Substances
  • Licensing and Inspections
  • Clinical Trials
  • Pharmacovigilance
  • Advertisements
  • General
  • New & Updates
  • COVID-19 Drugs Availability
  • Government of Pakistan COVID-19 Portal
  • National Command Operation Center (NCOC)
  • Ministry of NHSR&C
  • WHO – Coronavirus disease

Quick Navigation

     
  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem